Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post Triumph Gold Announces the Acquisition of the Coyote Knoll Silver-Gold Mineral Property – Located in Central Utah June 4, 2025 Next Post S&P 500 Bullish Patterns: Are Higher Highs Ahead? June 4, 2025 Related Posts Horn Island Project Update November 5, 2025 Sankamap Updates Status on Late Filing of Financial Statements November 5, 2025 Nextech3D.ai: Disrupting the Global Events Management Industry with AI and Blockchain November 5, 2025
Nextech3D.ai: Disrupting the Global Events Management Industry with AI and Blockchain November 5, 2025